Figure 4From: Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapyOverall survival by p-AKT (A; p-AKT < 80, n = 33, p-AKT ≥80, n = 35) and p-ERK (B; p-ERK < 80, n = 32, p-ERK ≥80 n = 36) expression.Back to article page